Baby Motrin drops recalled after plastic particles found

St. Louis area parents look to doctors and pharmaceutical companies as valuable partners in their effort to keep their babies and children healthy. Most of the time, parents are able to purchase medicines or other products that aid in their children’s well-being with no concerns at all. However, other times, problems can happen and sometimes when least expected. The importance of drug safety or the communication about drug recalls cannot be underestimated as vital elements of public health.

Nearly 200,000 0.5-ounce bottles of Concentrated Motrin Infants’ Drops Original Berry Flavor are being voluntarily recalled by the manufacturer due to the possibility that small plastic particles may be in the bottles. Such particles were found in some containers that had not yet been dispersed to the public at the McNeil Consumer Healthcare unit, a division of the pharmaceutical company Johnson & Johnson.

The plastic pieces are reported to be roughly the side of poppy seeds. The company stated that they do not believe the pieces would cause any harm or create any side effects but was pursuing the drug recall as a proactive matter of safety regulation. The particles were found to have been introduced from an ibuprofen supplier and the two companies are already discussing their plans to correct the issue.

Pharmaceutical liability is a serious issue and any parent who believes his or her child has received harmful drugs or been otherwise injured due to either a prescription or over-the-counter prescription can consult with an attorney to learn more about such product liability.

Source: FiercePharmaManufacturing, “J&J’s troubled McNeil unit recalls more products,” Eric Palmer, September 9, 2013